Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Implementing oral and long acting Pre-exposure prophylaxis in mobile men in Sub-Saharan Africa [MOBILE MEN]

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Rapid assessment report (si apre in una nuova finestra)

Determine barriers and motivators towards uptake of on-demand and injectable PrEP

Dissemination and exploitation plan (si apre in una nuova finestra)
Report of roles (si apre in una nuova finestra)

Confirmation of leadership and mentorship roles

Capacity strengthening plan (si apre in una nuova finestra)
Study initiation package (si apre in una nuova finestra)

Registration number of the clinical study in a registry meeting WHO Registry criteria. Final version of study protocol as approved by the regulator(s) / ethics committee(s). Regulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant.

Rapid assessment and other qualitative data collection (si apre in una nuova finestra)

Characteristics of men willing to take oral versus injectable PrEP

Draft stewardship plan (si apre in una nuova finestra)

Beneficiaries must prepare stewardship plans outlining how to achieve the optimal use of an intervention, including, for example, how to avoid irrational use, overuse or abuse of health technologies (e.g. antimicrobials). A draft plan must be submitted after half the duration of the project has elapsed and a final plan must be submitted with the final report.

Midterm recruitment report (si apre in una nuova finestra)

Midterm recruitment report. This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays. The Global Health EDCTP3 Joint Undertaking reserves the right to terminate the MOBILE MEN project if milestone MS16 has not been achieved and by month 18 no clinical trial participant has received long-acting cabotegravir.

Rapid assessment (si apre in una nuova finestra)

Characterize mobile men at risk of HIV

Consortium meeting (si apre in una nuova finestra)

Kick-off meeting and confirmation of committees

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile

Il mio fascicolo 0 0